Clinical Trials Search Results

  • Resize font
  • Print
  • Email
  • Facebook
  • Twitter
  • Google+
  • Pinterest
Display:
?
Cancer Type/Condition:  Rectal cancer
Stage/Subtype:  stage I rectal cancer
Trial Type:  Treatment
Results 1-8 of 8 for your search:
Start Over
Cyclodextrin-Based Polymer-Camptothecin CRLX10, Capecitabine, and Radiation Therapy before Surgery in Treating Patients with Locally Advanced Rectal Cancer
Status: Temporarily closed
Phase: Phase II, Phase I
Type: Treatment
Age: 18 and over
Trial IDs: LCCC 1315, NCI-2014-00897, NCT02010567
Chemoradiation or Brachytherapy before Surgery in Treating Patients with Rectal Cancer
Status: Active
Phase: Phase II
Type: Treatment
Age: 18 and over
Trial IDs: J1360, NCI-2014-00731, NA_00082167, NCI-2014-00125, NCT02017704
Exploratory Study of Safety and ex Vivo Fluorescence of BLZ-100 in Adult Subjects With Solid Tumors Undergoing Surgery
Status: Active
Phase: Phase I
Type: Treatment
Age: 18 and over
Trial IDs: BB-005, NCI-2016-00615, NCT02496065
Niclosamide in Treating Patients with Colon Cancer That Can Be Removed by Surgery
Status: Active
Phase: Phase I
Type: Biomarker/Laboratory analysis, Treatment
Age: 18 and over
Trial IDs: Pro00066964, NCI-2016-01245, NCT02687009
Hand Assisted Versus "Pure" Laparoscopic Assisted Proctectomy for Rectal Cancer
Status: Active
Phase: No phase specified
Type: Health services research, Treatment
Age: 18 and over
Trial IDs: MITT02, NCI-2014-02392, NCT00651677
A Study Assessing Perfusion Outcomes With PINPOINT® Near Infrared Fluorescence Imaging in Low Anterior Resection
Status: Active
Phase: No phase specified
Type: Diagnostic, Treatment
Age: 18 and older
Trial IDs: PP PLR 03, NCI-2015-01386, NCT02205307
Radiation Therapy with FOLFOX Chemotherapy in Treating Patients with Stage I Rectal Cancer
Status: Active
Phase: No phase specified
Type: Treatment
Age: 18 and over
Trial IDs: 201512140, NCI-2016-00011, NCT02641691
Nivolumab and Ipilimumab in Treating Patients with Rare Tumors
Status: Not yet active
Phase: No phase specified
Type: Treatment
Age: 18 and over
Trial IDs: S1609, NCI-2016-01041, NCT02834013
Start Over